| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | 11.45% | BMO Capital | $9.5 → $11 | Maintains | Market Perform |
| 10/26/2023 | 102.63% | Needham | → $20 | Reiterates | Buy → Buy |
| 08/14/2023 | -3.75% | BMO Capital | $10.5 → $9.5 | Maintains | Market Perform |
| 08/11/2023 | 102.63% | Needham | → $20 | Reiterates | Buy → Buy |
| 07/19/2023 | -8.81% | Barclays | $10 → $9 | Maintains | Equal-Weight |
| 05/19/2023 | 102.63% | Needham | → $20 | Reiterates | Buy → Buy |
| 05/18/2023 | 6.38% | BMO Capital | $11 → $10.5 | Maintains | Market Perform |
| 05/18/2023 | 92.5% | JMP Securities | → $19 | Reiterates | Market Outperform → Market Outperform |
| 05/18/2023 | 102.63% | Needham | → $20 | Reiterates | Buy → Buy |
| 05/18/2023 | 1.32% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 05/18/2023 | 1.32% | Citigroup | $12 → $10 | Maintains | Neutral |
| 05/08/2023 | 11.45% | BMO Capital | $13 → $11 | Downgrades | Outperform → Market Perform |
| 04/19/2023 | 102.63% | Needham | → $20 | Reiterates | → Buy |
| 03/20/2023 | 102.63% | Needham | → $20 | Reiterates | → Buy |
| 03/13/2023 | 92.5% | JMP Securities | $19 → $19 | Maintains | Market Outperform |
| 02/17/2023 | 21.58% | Citigroup | $11 → $12 | Maintains | Neutral |
| 02/16/2023 | 11.45% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 02/16/2023 | 31.71% | BMO Capital | $10.5 → $13 | Maintains | Outperform |
| 02/16/2023 | 31.71% | Wells Fargo | $12 → $13 | Maintains | Overweight |
| 02/16/2023 | 102.63% | Needham | → $20 | Reiterates | → Buy |
| 02/15/2023 | 92.5% | JMP Securities | → $19 | Maintains | Market Outperform |
| 01/12/2023 | 11.45% | Citigroup | $12 → $11 | Downgrades | Buy → Neutral |
| 11/16/2022 | 21.58% | Morgan Stanley | $13 → $12 | Maintains | Equal-Weight |
| 11/16/2022 | 21.58% | Goldman Sachs | $16 → $12 | Maintains | Buy |
| 11/16/2022 | 6.38% | BMO Capital | $14 → $10.5 | Maintains | Outperform |
| 10/20/2022 | 31.71% | Morgan Stanley | $14 → $13 | Maintains | Equal-Weight |
| 10/18/2022 | -8.81% | Barclays | $15 → $9 | Downgrades | Overweight → Equal-Weight |
| 09/13/2022 | 183.69% | JMP Securities | $28 → $28 | Maintains | Market Outperform |
| 08/12/2022 | 41.84% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 08/11/2022 | 183.69% | JMP Securities | $28 → $28 | Maintains | Market Outperform |
| 07/14/2022 | 41.84% | Goldman Sachs | $18 → $14 | Maintains | Buy |
| 06/07/2022 | 62.11% | Wells Fargo | $18 → $16 | Maintains | Overweight |
| 06/07/2022 | 31.71% | Morgan Stanley | → $13 | Reinstates | → Equal-Weight |
| 06/07/2022 | 82.37% | Citigroup | $22 → $18 | Maintains | Buy |
| 05/26/2022 | 1.32% | BMO Capital | $14 → $10 | Maintains | Outperform |
| 05/25/2022 | 51.98% | Barclays | $23 → $15 | Maintains | Overweight |
| 05/24/2022 | 41.84% | BMO Capital | $19 → $14 | Maintains | Outperform |
| 05/24/2022 | 82.37% | Goldman Sachs | $23 → $18 | Maintains | Buy |
| 05/24/2022 | 82.37% | Wells Fargo | $20 → $18 | Maintains | Overweight |
| 05/24/2022 | 102.63% | Needham | $40 → $20 | Maintains | Buy |
| 05/24/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 05/23/2022 | 183.69% | JMP Securities | → $28 | Maintains | Market Outperform |
| 04/27/2022 | 133.03% | Goldman Sachs | → $23 | Initiates Coverage On | → Buy |
| 04/25/2022 | 102.63% | Keybanc | $23 → $20 | Maintains | Overweight |
| 03/15/2022 | 102.63% | Wells Fargo | $24 → $20 | Maintains | Overweight |
| 02/17/2022 | 295.14% | JMP Securities | $39 → $39 | Maintains | Market Outperform |
| 02/17/2022 | 143.16% | Citigroup | $23 → $24 | Maintains | Buy |
| 02/17/2022 | 143.16% | Wells Fargo | $30 → $24 | Maintains | Overweight |
| 01/26/2022 | 203.95% | Wells Fargo | $40 → $30 | Maintains | Overweight |
| 11/11/2021 | 264.74% | Barclays | $42 → $36 | Maintains | Overweight |
| 07/12/2021 | 315.4% | Morgan Stanley | → $41 | Initiates Coverage On | → Overweight |
| 07/12/2021 | 305.27% | Wells Fargo | → $40 | Initiates Coverage On | → Overweight |
| 07/12/2021 | 295.14% | JMP Securities | → $39 | Initiates Coverage On | → Market Outperform |
| 07/12/2021 | 305.27% | Citigroup | → $40 | Initiates Coverage On | → Buy |
| 07/12/2021 | 264.74% | Barclays | → $36 | Initiates Coverage On | → Overweight |
| 07/12/2021 | 305.27% | Needham | → $40 | Initiates Coverage On | → Buy |
| 07/12/2021 | 376.19% | Goldman Sachs | → $47 | Initiates Coverage On | → Buy |
| 07/12/2021 | 254.61% | BMO Capital | → $35 | Initiates Coverage On | → Outperform |
| 07/12/2021 | 325.53% | Keybanc | → $42 | Initiates Coverage On | → Overweight |
What is the target price for WalkMe (WKME)?
The latest price target for WalkMe (NASDAQ: WKME) was reported by BMO Capital on November 15, 2023. The analyst firm set a price target for $11.00 expecting WKME to rise to within 12 months (a possible 11.45% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for WalkMe (WKME)?
The latest analyst rating for WalkMe (NASDAQ: WKME) was provided by BMO Capital, and WalkMe maintained their market perform rating.
When is the next analyst rating going to be posted or updated for WalkMe (WKME)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of WalkMe, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for WalkMe was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating WalkMe (WKME) correct?
While ratings are subjective and will change, the latest WalkMe (WKME) rating was a maintained with a price target of $9.50 to $11.00. The current price WalkMe (WKME) is trading at is $9.87, which is within the analyst's predicted range.